We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

203 hedge funds and large institutions have $2.16B invested in Regenxbio in 2018 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 92 increasing their positions, 49 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 21

88% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 49

15% more capital invested

Capital invested by funds: $1.87B → $2.16B (+$289M)

15% more funds holding

Funds holding: 177 → 203 (+26)

0.19% more ownership

Funds ownership: 81.49% → 81.68% (+0.19%)

17% less call options, than puts

Call options by funds: $10.3M | Put options by funds: $12.4M

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
203
Holders Change
+26
Holders Change %
+14.69%
% of All Funds
4.64%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
48
Increased
92
Reduced
49
Closed
21
Calls
$10.3M
Puts
$12.4M
Net Calls
-$2.12M
Net Calls Change
-$6.82M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$68.3M
2
BlackRock
BlackRock
New York
+$36.6M
3
Citadel Advisors
Citadel Advisors
Florida
+$32.9M
4
State Street
State Street
Massachusetts
+$26M
5
Renaissance Technologies
Renaissance Technologies
New York
+$20.6M

Top Sellers

1
RI
RTW Investments
New York
-$44.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$38.1M
3
PA
Perceptive Advisors
New York
-$28.6M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$21.5M
5
Citigroup
Citigroup
New York
-$7.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
201
SeaCrest Wealth Management
New York
$1K +$1.08K +15 New
Adage Capital Partners
202
Adage Capital Partners
Massachusetts
– -$21.5M -300,000 Closed
VC
203
Vivo Capital
California
– -$5.91M -82,403 Closed
PP
204
PDT Partners
New York
– -$3.08M -42,946 Closed
Hudson Bay Capital Management
205
Hudson Bay Capital Management
Connecticut
– -$2.87M -40,000 Closed
Lazard Asset Management
206
Lazard Asset Management
New York
– -$1.36M -18,932 Closed
ACM
207
Asymmetry Capital Management
California
– -$1.2M -16,692 Closed
FAM
208
Fred Alger Management
New York
– -$933K -13,000 Closed
SEI Investments
209
SEI Investments
Pennsylvania
– -$899K -12,527 Closed
ARTA
210
A.R.T. Advisors
New York
– -$722K -10,064 Closed
SGA
211
Sector Gamma AS
Norway
– -$718K -10,000 Closed
BCA
212
Bay Colony Advisors
Massachusetts
– -$696K -9,700 Closed
Squarepoint
213
Squarepoint
New York
– -$483K -6,725 Closed
II
214
Ibex Investors
Colorado
– -$417K -5,811 Closed
KBC Group
215
KBC Group
Belgium
– -$347K -4,840 Closed
AB
216
Amalgamated Bank
New York
– -$332K -4,622 Closed
CSS
217
Cubist Systematic Strategies
Connecticut
– -$299K -4,163 Closed
SPC
218
Sigma Planning Corp
Michigan
– -$228K -3,180 Closed
PCM
219
Penserra Capital Management
California
– -$121K -1,692 Closed
WAP
220
Wealthcare Advisory Partners
Pennsylvania
– -$72K -1,000 Closed
PO
221
Private Ocean
California
– -$36K -500 Closed
HIM
222
Hillsdale Investment Management
Ontario, Canada
– -$9K -130 Closed
JA
223
JOYN Advisors
Georgia
– +$216 +3 New
CAG
224
Csenge Advisory Group
Florida
– +$648 +9 New
5 6 7 8
9

RGNX Hedge Fund Activity: Q3 2018 in Review

203 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2018, worth a combined $2.16B — up 15% from $1.87B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new RGNX positions and 21 closed out — a net gain of 27 holders — while 92 added to existing stakes and 49 trimmed.

The largest buyer was Vanguard Group, adding an estimated $68.3M. The largest seller was RTW Investments, cutting an estimated $44.7M.

  • 203 institutional investors held Regenxbio (RGNX) as of Q3 2018, up from 177 in Q2 2018.
  • Funds reported $2.16B of Regenxbio stock for Q3 2018, up 15% quarter-over-quarter.
  • 48 funds opened new Regenxbio positions in Q3 2018 and 21 closed out, a net change of +27 holders.
  • The largest Regenxbio buyer in Q3 2018 was Vanguard Group, an estimated $68.3M added.
  • The largest Regenxbio seller in Q3 2018 was RTW Investments, an estimated $44.7M sold.

Based on aggregated 13F filings for Q3 2018.